PeptidesDNA
CJC-1295 peptide vial
📈 Growth Hormone

CJC-1295

CJC-1295 (Modified GRF 1-29)

Also called CJC1295, mod GRF 1-29, modified GRF (1-29), DAC:GRF

The GH amplifier

CJC-1295 copies the brain signal that tells the pituitary to release growth hormone. It comes in two versions that behave very differently: with DAC it lasts days, without DAC it lasts minutes. Blends sold with Ipamorelin nearly always use the short-acting one, which is why dosing advice for it contradicts itself everywhere.

A copy of the brain signal that tells the pituitary to release growth hormone, rewritten so the enzyme that normally destroys it in minutes cannot. Before you read any dose, check which version you have: with DAC it keeps growth hormone up for days, without DAC it produces a short pulse, and nearly every blend sold with ipamorelin contains the second one.

Half-life
6–8 days (with DAC); 30 min–2 hr (without DAC)
Typical dose
100 mcg/injection (no DAC) or 2 mg/week (DAC)
Availability
Research-only
Moderate Evidence

Studied in people, and well studied in animals

32 papers · 2 clinical trials

What people use CJC-1295 for

Reported uses, roughly in order of how often they are the reason someone goes looking. Whether it works for any of them is a separate question, answered under each one.

Growth hormone support
The only effect directly demonstrated in humans, and it was demonstrated with the long-acting DAC version.
Body composition
Reasoned from what growth hormone does, not shown for this compound.
Recovery and sleep
Common reasons people take it, resting on the same extrapolation.

Mechanism of Action

How CJC-1295 works

Your brain sends a short message to the pituitary meaning release growth hormone. It has to be short-lived, because a signal that never stops is not a signal. An enzyme in your blood chops it up within minutes.

CJC-1295 is that message rewritten to survive the chopping. A few amino acids in the chain were swapped for ones the enzyme cannot cut.

The one thing you have to check before anything else

This compound exists in two versions, and they behave so differently that they are effectively different drugs.

The version with DAC carries an extra attachment that lets it hitch onto a protein in your blood and ride around for days. Growth hormone stays elevated the whole time. In healthy adults, a single injection raised it several-fold for six days or more.

The version without DAC, often sold as mod GRF 1-29, clears in minutes. You get a pulse and then nothing, which is much closer to how your body does it naturally.

Nearly every blend sold with ipamorelin contains the second one. Nearly every dosing chart quotes the trial that used the first. That single mismatch is why advice about this compound contradicts itself everywhere you look, and checking which one is in your vial resolves most of the confusion by itself.

An open question nobody settles

Your body releases growth hormone in pulses rather than a steady stream, and that pattern appears to matter. The DAC version deliberately overrides it and holds levels up continuously. Whether that is better than pulses, or worse, has not been established. It is a genuine unknown rather than a technicality.

CJC-1295 dosage calculator

Opens at 100 mcg, from the doses reported for CJC-1295. Change any box to match your own vial. It works out where to pull the plunger to.

How much is in the vial?

Printed on the label, in milligrams

How much water did you add?

Bacteriostatic water, in millilitres

What dose are you taking?

The dose you already intend to use

Which syringe?

Barrel size, printed on the wrapper

Draw to

2 units

on a 0.5 mL insulin syringe (0.02 mL)

10203040502 units
Strength once mixed
5 mg/mL
Doses in the vial
100

10 mg in 2 mL makes 5 mg/mL. A 100 mcg dose is 0.02 mL of that, which is 2 units.

Want a rounder number? Adding 10 mL instead would put this dose at exactly 10 units, which is easier to draw accurately.

This is arithmetic, not advice. It converts a dose you already have into a mark on a syringe. It does not tell you what dose to take, and CJC-1295 is not prescribed by us. Dosing belongs with a qualified clinician.

Full reconstitution chart and worked examples.

CJC-1295 side effects: what people reported

Most of what people report comes from holding water, which is what happens when growth hormone goes up. It is usually worst in the first couple of weeks and settles.

What most people notice

  • Puffiness, especially hands and face, in the first weeks
  • A head rush or flushing in the minutes after injecting
  • Vivid dreams and heavier sleep, since it works overnight
  • Injection-site redness
  • Tiredness the next morning early on

Worth keeping an eye on

  • Numbness or tingling in the hands, from fluid pressing on the nerve at the wrist. It is the most common reason people lower the dose
  • Aching joints
  • Blood sugar drifting up, since growth hormone works against insulin

Dose matters. Water retention and the tingling that comes with it track the dose and ease when people drop it.

Source: Trial data plus widely reported use. This is a summary of published findings, not a complete safety profile and not medical advice. CJC-1295 should only be considered with a qualified clinician who knows your history.

Your Genetics & CJC-1295

The genes involved in how CJC-1295 works

CJC-1295 works through the receptors these genes build, and the genes vary from person to person. Researchers have linked some of that variation to differences in how people respond. A DNA report tells you which versions you carry.

Chromosome 7Growth hormone releasing hormone receptor

GHRHR · ••

Variants in the GHRH receptor gene affect receptor density and binding affinity on pituitary somatotrophs. Reduced receptor expression means fewer targets for CJC-1295, potentially requiring dose adjustment to achieve equivalent GH elevation.

Chromosome 5Growth hormone receptor (d3/fl polymorphism)

GHR · ••

The GHR exon 3 deletion (d3-GHR) creates a shorter receptor with increased GH sensitivity. d3 carriers may achieve greater IGF-1 response from the same CJC-1295-induced GH pulse, potentially needing lower doses.

IGF1IGF-1 production

Promoter region variants affect baseline IGF-1 levels. Low-IGF1 genotypes may see more dramatic improvements from CJC-1295, while high-baseline carriers may need monitoring to avoid supraphysiological IGF-1.

SOCS2GH signal regulation

SOCS2 is a negative regulator of GH signaling — it puts the brakes on the JAK/STAT pathway. Variants reducing SOCS2 function may amplify CJC-1295's downstream effects, increasing sensitivity to GH pulses.

The dots after each gene are where your own result goes. Your report fills them in with the two letters you carry at that position.

Which variants do you carry?

Upload your DNA data, or get tested through our partner, to find out.

Get Your Report — $99

Commonly combined with

What CJC-1295 is most often paired with, and why:

Ipamorelin

GH Synergy StackModerate Evidence

Ipamorelin Acetate

Presses the same switch your stomach uses to say it is empty, the one that also triggers a growth hormone release, but largely without the hunger. Its selling point is what it does not do: older peptides in its family also pushed up cortisol and prolactin, and this one mostly stops at growth hormone. It is almost always sold blended with CJC-1295.

4

Gene variants

40+

Studies

BPC-157

Recovery StackModerate Evidence

Body Protection Compound 157

BPC-157 is the peptide people reach for when something will not heal. Tendons, ligaments, a gut that has been irritated by painkillers, an injury that has stalled. It is a short chain of amino acids copied from part of a protein your stomach already makes, and the animal research on it is unusually consistent for this category: across a lot of separate rat studies, injured tissue healed faster than it did without it. The gap is that this has largely not been repeated in people, and it is not an approved medicine, so nobody is checking what is in the vial you buy.

3

Gene variants

19+

Studies

MK-677 (Oral GH Support)

Sourcing & access

Where to buy CJC-1295

CJC-1295 is sold as a research compound, not a licensed medicine, so quality and legal status vary widely by country and vendor. If you're sourcing it, treat independent purity testing as non-negotiable.

  • Insist on a recent third-party Certificate of Analysis (COA) for the exact batch — labs like Janoshik verify purity and identity.
  • Check the legal status where you live before ordering — it differs from country to country.
  • Reconstitute correctly with bacteriostatic water and start at a conservative dose.
CJC-1295 vial

CJC-1295

The GH amplifier

Buy at Swiss Chems

Save 10% at checkout with code tcwisiiu

Before you buy: see whether your DNA actually responds to CJC-1295, and at what dose. Analyze my DNA — $99 →

Educational information only, not medical advice. Some outbound links are affiliate links (disclosed, at no extra cost to you). Most peptides are not FDA-approved — consult a qualified professional and check your local laws before purchasing.

Worth knowing before you consider CJC-1295

Interactions and situations where there is a specific reason to be careful. Where the honest answer is that nobody has studied something, it says so and says what that leaves open.

With DAC and without DAC are effectively two different drugs
With DAC it holds growth hormone elevated for days; without it, often sold as mod GRF 1-29, you get a short pulse closer to the body's own rhythm. Check which one is in your vial before reading any protocol, because the same number means different things for each.
Sustained elevation is not obviously the goal
Your body releases growth hormone in pulses, and that pattern appears to matter. The DAC version deliberately overrides it. Whether continuous elevation is better or worse than pulses has not been settled, which is a real open question rather than a technicality.
Not an approved medicine, and banned in sport
It is not approved anywhere, is not on the 503A list for compounding, and is prohibited at all times under WADA rules.

The evidence behind CJC-1295

One human trial matters here and it is a good one, but read which version it used. Teichman 2006 tested CJC-1295 with DAC, the long-acting form, and showed clear, prolonged rises in growth hormone and IGF-1. The blends sold with Ipamorelin almost always contain the version without DAC, which clears in minutes and produces a pulse instead. Doses and expectations do not transfer between the two, and most pages quoting this trial do not mention which one they are describing.

The literature, counted

Counted in PubMed on 3 August 2026 for CJC-1295. Every figure links to the search that produced it, so you can re-run it. “Tagged human” is not the same as a human trial: that tag also covers work on human cells and reviews discussing people, which is why the trial count is given separately.

Every source behind this page4
  1. Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine PhysiciansMayfield CK, Bolia IK, Feingold CL, et al. · American Journal of Sports Medicine · 2026Review
  2. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic PerformanceMendias CL, Awan TM · Sports Medicine · 2026Review

Everything we cite for CJC-1295, including animal work and early research. Each link goes to the source itself, so you can judge it rather than take our word for it.

Last updated · literature counts verified against PubMed on

Frequently Asked Questions

What is CJC-1295 used for?

CJC-1295 is used to amplify natural growth hormone production for body composition, recovery, anti-aging, and sleep quality. It extends the duration of your natural GH pulses rather than replacing them, making it a physiologically conservative approach to GH optimization.

Why stack CJC-1295 with Ipamorelin?

CJC-1295 (GHRH analog) and Ipamorelin (ghrelin mimetic) work through different receptors. CJC-1295 amplifies pulse duration while Ipamorelin increases pulse amplitude. Together, they produce synergistic GH elevation — typically 2-3x more than either alone — while maintaining pulsatile release patterns.

Does genetics affect CJC-1295 response?

Yes. GHRHR variants affect how many receptor targets CJC-1295 has on your pituitary. The GHR d3 deletion determines downstream GH sensitivity. IGF1 promoter variants set your baseline, influencing how much room there is for improvement. A genetic peptide report maps these factors.

Learn more about CJC-1295

41 guides mention CJC-1295

Your next move

Two ways forward with CJC-1295.

Not sure it's for you?

How does CJC-1295 relate to your genes?

Your report scores CJC-1295 against your receptor, pharmacogene and pathway variants and shows the genetic markers relevant to it, with commonly cited dosing information to review with a clinician.

Analyze my DNA — $99

Already decided?

Get CJC-1295 from Swiss Chems.

A US research-chemical supplier with third-party Certificates of Analysis. Sold for research use only — check your local laws before ordering.

Buy at Swiss Chems →

Save 10% at checkout with code tcwisiiu

See your DNA match